Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCZ696 vs enalapril in chronic heart failure (PARADIGM-HF China)
CTR20131676Phase 3Completed
- Sponsor
- Novartis
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sacubitril + valsartan in chronic heart failure (CHF), sponsored by Novartis. Started Aug 2014; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on CTR20131676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131676.